Neurogene Overview
Neurogene Target Price
Analysts' 12-month price predictions for NGNE.
Get informed when a big investor buys or sells
+ FollowShare Price
$26.22
Average Target Price
$69.00
163.2% upside
163.2% upside1 analysts in the last 4 months
High: $69 | Low: $69
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-28 | Guggenheim | $69 | 163.2% upside |  |
| 2025-10-02 | H.C. Wainwright | $45 | 71.6% upside | |
| 2025-04-14 | BMO CapitalKeith Tapper | $16 |  39% downside | |
| 2025-03-25 | Robert W. BairdJoel Beatty | $38 | 44.9% upside | |
| 2025-03-25 | H.C. WainwrightMitchell Kapoor | $50 | 90.7% upside | |
| 2024-11-20 | Stifel NicolausPaul Matteis | $46 | 75.4% upside | |
| 2024-11-19 | BMO CapitalKeith Tapper | $45 | 71.6% upside | |
| 2024-11-12 | BMO CapitalKeith Tapper | $60 | 128.8% upside | |
| 2024-11-12 | Stifel NicolausPaul Matteis | $60 | 128.8% upside | |
| 2024-08-12 | H.C. WainwrightMitchell Kapoor | $49 | 86.9% upside | |
| 2024-06-26 | BMO CapitalKeith Tapper | $65 | 147.9% upside | |
| 2024-06-10 | Robert W. BairdJoel Beatty | $54 | 105.9% upside | |
| 2024-05-13 | H.C. WainwrightMitchel Kapoor | $51 | 94.5% upside | |